New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis

By Ding Qiang   Luckhardt Tracy   Hecker Louise   Zhou Yong   Liu Gang   Antony Veena B.   deAndrade Joao   Thannickal Victor J.  

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 981-1001

Adis International

Access to resources Recommend Favorite

Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 3, 2010-07 ,pp. : 158-172

Bentham Science Publishers

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

By Antoniu Sabina A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1443-1447

Informa Healthcare

Access to resources Recommend Favorite

Molecular Mechanisms of and Possible Treatment Strategies for Idiopathic Pulmonary Fibrosis

By  

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3943-3971

Bentham Science Publishers

Access to resources Recommend Favorite